Tirzepatide
Dual GIP/GLP-1 receptor agonist compounded for individual patients. Licensed 503A pharmacy with third-party potency testing and wholesale pricing. Now serving providers in the New York City, New York area.
About
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in medical weight management. Originally marketed as Mounjaro® and Zepbound® by Eli Lilly, compounded tirzepatide is available from licensed 503A pharmacies for individual patients when commercially manufactured versions are unavailable or in shortage.
Promise Pharmacy compounds tirzepatide in multiple concentrations to support standard dose titration protocols. Each vial is prepared for an individual patient based on a valid prescription from a licensed provider.
Process
Apply through our partner program with your medical license and DEA registration.
Choose the tirzepatide concentration matching your titration protocol.
Submit individual patient prescriptions through the provider portal.
We compound and ship within 5 business days with proper cold chain packaging.
FAQ
Service Area
Promise Pharmacy provides GLP-1 weight loss services to licensed healthcare providers in New York City, NY and the surrounding New York area. Whether you operate a weight loss clinic, hormone optimization practice, telehealth platform, or multi-specialty group, our pharmacy ships compounded medications directly to your practice or your patients in New York City.
With 98,000+ licensed prescribers across New York, the Northeast region represents a significant market for compounded medications. Providers in New York City, NY benefit from our 5-day fulfillment guarantee, wholesale pricing, dedicated account management, and third-party potency and sterility testing on every batch. Every compounded medication is prepared under USP 795, 797, and 800 standards with a Certificate of Analysis available through your provider portal.
New York has stringent nonresident pharmacy requirements and requires additional documentation for compounded medications. Promise Pharmacy is licensed by the New York State Board of Pharmacy as a nonresident compounding pharmacy and maintains compliance with all state-specific requirements. New York has limited telehealth prescribing rules — certain medication categories may require an in-person visit. For detailed guidance on 503A compounding regulations, see our guide: 503A vs 503B Compounding Pharmacy.
Promise Pharmacy supports GLP-1 weight loss providers across every practice model in New York City: brick-and-mortar clinics, multi-location groups, solo practitioners, telehealth-first platforms, and concierge medicine practices. Our provider portal enables online ordering, prescription management, shipment tracking, and Certificate of Analysis downloads — all accessible from any device.
We also offer white-label compounding for practices that want branded packaging, wholesale programs for high-volume clinics, and in-office dispensing support for practices that dispense on-site. Open a provider account to start ordering for your New York City practice.
Why Compounding
| Feature | Promise Compounding | Commercial Pharmacy |
|---|---|---|
| Customized Dosing | Yes — any concentration per protocol | Fixed manufacturer doses only |
| Provider Pricing | Wholesale per-vial pricing | Retail or PBM-contracted rates |
| Supply Reliability | In-house manufacturing — no shortage gaps | Subject to manufacturer supply chain |
| Direct-to-Patient Ship | Yes — nationwide in licensed states | Varies by pharmacy chain |
| Quality Testing | 3rd-party potency + sterility on every batch | Manufacturer batch testing only |
| Account Management | Dedicated account manager + clinical pharmacist | Standard retail counter service |
| Portal Access | Online ordering, tracking, and COA downloads | Typically phone/fax only |
FAQ
More Services in New York